Acta Neuropathologica SCIESCI

Acta Neuropathologica aims to publish the best papers on pathology of neurological disease, as well as experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues.

The journal publishes Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters).

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identiy of the subjects under study should be omitted.

Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.

The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.

Acta Neuropathologica 旨在发表关于神经疾病病理学的最佳论文，以及使用体外和体内模型对分子和细胞机制进行的实验研究，并通过人体组织分析进行理想验证。

该期刊发表原创论文、评论文章、案例报告和科学通信（信件）。

提交出版的手稿必须包含一项声明，说明所有人体研究都已经过相应的伦理委员会审查，因此已按照 1964 年赫尔辛基宣言的适当版本中规定的伦理标准进行。还应在正文中明确说明所有人员在纳入研究之前均已签署知情同意书。应省略可能泄露研究对象身份的细节。

动物实验报告必须说明遵循“实验动物护理原则”（NIH 第 86-23 号出版物，1985 年修订）以及特定的国家法律（例如现行版本的德国动物保护）（如适用）。

编辑保留拒绝不符合上述要求的稿件的权利。如有虚假陈述或未能满足上述要求，作者将承担责任。

该刊已被国际权威数据库SCIE、SCI收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映病理学-医学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为12.7，平均审稿速度为偏慢,4-8周，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。